Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets
- PMID: 26837042
- DOI: 10.1016/j.mcn.2016.01.012
Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets
Abstract
Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases.
Keywords: Amyotrophic lateral sclerosis; Authophagy; Protein aggregation.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.Neurobiol Aging. 2014 May;35(5):941-57. doi: 10.1016/j.neurobiolaging.2013.11.019. Epub 2013 Nov 28. Neurobiol Aging. 2014. PMID: 24360503 Review.
-
Dysfunction of autophagy as the pathological mechanism of motor neuron disease based on a patient-specific disease model.Neurosci Bull. 2015 Aug;31(4):445-51. doi: 10.1007/s12264-015-1541-9. Epub 2015 Jul 28. Neurosci Bull. 2015. PMID: 26219222 Free PMC article. Review.
-
Autophagy and apoptosis dysfunction in neurodegenerative disorders.Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Prog Neurobiol. 2014. PMID: 24211851 Review.
-
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease.Int J Mol Sci. 2019 Feb 8;20(3):728. doi: 10.3390/ijms20030728. Int J Mol Sci. 2019. PMID: 30744070 Free PMC article. Review.
-
Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis.Biochim Biophys Acta. 2015 Nov;1852(11):2517-24. doi: 10.1016/j.bbadis.2015.08.005. Epub 2015 Aug 8. Biochim Biophys Acta. 2015. PMID: 26264610 Review.
Cited by
-
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.CNS Neurosci Ther. 2018 Dec;24(12):1163-1174. doi: 10.1111/cns.12855. Epub 2018 Apr 14. CNS Neurosci Ther. 2018. PMID: 29656576 Free PMC article.
-
New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis.J Cell Sci. 2016 Nov 1;129(21):4118-4129. doi: 10.1242/jcs.190298. Epub 2016 Sep 21. J Cell Sci. 2016. PMID: 27656112 Free PMC article.
-
A transition to degeneration triggered by oxidative stress in degenerative disorders.Mol Psychiatry. 2021 Mar;26(3):736-746. doi: 10.1038/s41380-020-00943-9. Epub 2020 Nov 6. Mol Psychiatry. 2021. PMID: 33159186 Free PMC article. Review.
-
Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles.Cell Death Dis. 2021 Apr 12;12(4):392. doi: 10.1038/s41419-021-03669-w. Cell Death Dis. 2021. PMID: 33846297 Free PMC article.
-
No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study.Sci Rep. 2020 Aug 7;10(1):13371. doi: 10.1038/s41598-020-70373-8. Sci Rep. 2020. PMID: 32770128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

